(Press-News.org) FINDINGS
A UCLA-led study found treatments that reduce the risk of being diagnosed with a cancer recurrence based on rising prostate-specific antigen (PSA) levels after radiotherapy, commonly referred to as biochemical recurrence, do not necessarily improve a patient’s long-term overall survival.
The team of investigators found that while biochemical recurrence was associated with a higher risk of death, it still did not meet the criteria to be a reliable surrogate endpoint for overall survival. As defined by the FDA, a clinical outcome directly measures whether people in a trial feel or function better, or live longer. A surrogate endpoint is a specific, relatively early outcome that reliably predicts for a clinical outcome that occurs in the longer-term.
Biochemical recurrences occur much earlier in the disease course than metastases or survival, and could potentially be the ideal surrogate endpoint for prostate cancer. Therefore, the team evaluated whether biochemical recurrence could be a useful surrogate endpoint for death. This has implications for not only designing clinical trials, but also for evaluating the benefit of various forms of treatment intensification and for counseling patients.
“One reason for our finding could be that many patients in the study died from causes unrelated to prostate cancer,” said Dr. Amar Kishan, an associate professor of radiation oncology at the David Geffen School of Medicine at UCLA and a researcher at the UCLA Health Jonsson Comprehensive Cancer Center, and senior author of the study. “The strength of the correlation between biochemical recurrence and overall survival varied depending on how deaths from non-cancer-related causes were accounted for. However, it is important to note that we looked specifically at death, and not at quality of life. Certainly, biochemical recurrence could impact quality of life. Unfortunately, high-level data tracking this are lacking, and it is something our group, and others, are hoping to explore further.”
BACKGROUND
Biochemical recurrence develops in almost one-third of men with prostate cancer after treatment with prostatectomy or radiation therapy for localized prostate cancer. It often occurs early on in the course of prostate cancer and indicates the cancer might be coming back. Because of this, it has been theorized to be a potential marker to predict a patient’s overall survival outcome. However, previous analyses have yielded conflicting conclusions about whether or not biochemical recurrence could be a reliable predictor of overall survival for patients treated for prostate cancer.
METHOD
The researchers collected and analyzed data from 11 different studies evaluating radiation therapy dose escalation, the use of androgen deprivation therapy and androgen deprivation therapy prolongation to evaluate the potential of biochemical recurrence as a predictor of survival. Overall, 10,741 patients were included in the analysis.
IMPACT
Despite the potential of using biochemical recurrence as a potential marker to predict overall survival in patients with prostate cancer, the results of the study indicates that it should not be the main focus or primary measure in future clinical trials for localized prostate cancer. Instead, metastasis-free survival, which refers to the period without cancer spreading to other parts of the body, is a more suitable endpoint for future trials involving radiation therapy in localized prostate cancer cases.
AUTHORS
The senior and corresponding author is Kishan. The co-first authors are Tahmineh Romero from UCLA and Dr. Soumyajit Roy from Rush University Medical Center. The complete list of authors can be found in the journal article.
JOURNAL
The study was published in the Journal of Clinical Oncology.
FUNDING
The work was supported in part by grants from the Prostate Cancer National Institutes of Health Specialized Programs of Research Excellence (P50CA09213), the Department of Defense (PC210066), the Prostate Cancer Foundation and the American Society for Radiation Oncology.
END
PSA levels after treatment may not be reliable predictor of survival for patients with prostate cancer
2023-08-28
ELSE PRESS RELEASES FROM THIS DATE:
Two networks, two realities, one big problem
2023-08-28
National news coverage from the two largest broadcast outlets, CNN and Fox News, not only reflects growing political polarization in America, but in a recent publication, researchers at Virginia Tech have shown that partisan and inflammatory broadcast coverage has increased over time and can exacerbate growing divides in the new public square of social media.
Collaborative insights
Eugenia Rho is assistant professor in the Department of Computer Science with a background in political science and a passion for ...
The physics of fat droplets reveal DNA danger
2023-08-28
Fat is a normal and necessary part of the body. Fat cells store and release energy, as well as play significant roles in hormonal regulation and immunity.
In recent decades, a concerning rise in metabolic illnesses – such as cardiovascular disease, high blood pressure and diabetes – has focused scientific attention on the biology and chemistry of fat, resulting in a wealth of information about how fat cells work.
But fat cells and their metabolic activities are only part of the story.
Fat-filled lipid droplets, tiny spheres ...
SfN’s TPDA Program earns ASAE 2023 Power of Associations Gold Award
2023-08-28
WASHINGTON, D.C. – The Society for Neuroscience (SfN) earned a Power of Associations Gold Award from the American Society of Association Executives (ASAE) for its successful Trainee Professional Development Award (TPDA) program. ASAE’s Power of Association awards celebrate and promote the invaluable contributions that associations make within the U.S. and globally through catalytic initiatives focused on professional advancement, global development, diversity and inclusion practices, advocacy, and community support and engagement.
In operation since 2015, the TPDA program recognizes undergraduate and graduate ...
New approach to fighting malaria
2023-08-28
RIVERSIDE, Calif. -- The mosquito-borne infectious disease malaria resulted in about 241 million clinical episodes and 627,000 deaths in 2020. In young children and pregnant women living in areas where the disease is endemic, a major cause of death is Plasmodium falciparum, the most virulent, prevalent, and deadly human malaria parasite.
Scientists are keen to understand the mechanisms that regulate gene expression through the different stages of P. falciparum’s lifecycle because such knowledge can ...
UMass Amherst computer scientists use AI to accelerate computing speed by thousands of times
2023-08-28
AMHERST, Mass. – A team of computer scientists at the University of Massachusetts Amherst, led by Emery Berger, recently unveiled a prize-winning Python profiler called Scalene. Programs written with Python are notoriously slow—up to 60,000 times slower than code written in other programming languages—and Scalene works to efficiently identify exactly where Python is lagging, allowing programmers to troubleshoot and streamline their code for higher performance.
There are many different programming ...
Rare disease shares mechanism with cystic fibrosis
2023-08-28
Aug. 28, 2023
Images
ANN ARBOR—University of Michigan researchers have discovered that the same cellular mechanism involved in a form of cystic fibrosis is also implicated in a form of a rare disease called cystinosis.
The mechanism cleans up mutated proteins. In cystinosis, a genetic disease, this allows cystine crystals to build up in the cell. This disrupts the cell, and eventually, tissues and ultimately organs, particularly the kidneys and the eyes.
The problem begins when the lysosome, an organelle within the cell, is unable to ...
Once rhabdomyosarcoma, now muscle
2023-08-28
“Every successful medicine has its origin story. And research like this is the soil from which new drugs are born,” says Cold Spring Harbor Laboratory Professor Christopher Vakoc.
For six years, Vakoc’s lab has been on a mission to transform sarcoma cells into regularly functioning tissue cells. Sarcomas are cancers that form in connective tissues like muscle. Treatment often involves chemotherapy, surgery, and radiation—procedures that are especially tough on kids. If doctors could transform cancer cells into healthy cells, it would offer patients a whole new treatment option—one that could spare them and their families a great deal of ...
Past abrupt changes in North Atlantic Overturning have impacted the climate system across the globe
2023-08-28
The Dansgaard-Oeschger events are rapid Northern-Hemisphere temperature jumps of up to 15°C in Greenland that repeatedly occurred within a few decades during the last ice age. “These events are the archetype of abrupt climate changes and further increasing our understanding of them is crucial for more reliable assessments of the risk and possible impacts of future large-scale climate tipping events”, says Niklas Boers from the Potsdam Institute for Climate Impact Research (PIK) and the Technical University of Munich, one of the authors of the study to be published in the Proceedings of the National Academy of Sciences PNAS.
In the ...
Historic red tide event of 2020 fueled by plankton super swimmers
2023-08-28
A major red tide event occurred in waters off Southern California in the spring of 2020, resulting in dazzling displays of bioluminescence along the coast. The spectacle was caused by exceedingly high densities of Lingulodinium polyedra (L. polyedra), a plankton species renowned for its ability to emit a neon blue glow. While the red tide captured the public’s attention and made global headlines, the event was also a harmful algal bloom. Toxins were detected at the height of the bloom that had the potential to harm marine life, and dissolved oxygen levels dropped to near-zero as the extreme biomass of the red tide decomposed. This lack of oxygen led to fish die-offs ...
Intravascular imaging associated with improved outcomes compared with angiography
2023-08-28
Amsterdam, Netherlands – 27 Aug 2023: Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided PCI, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.1
Numerous randomised trials have compared intravascular imaging-guided PCI with angiography-guided PCI. However, most of these prior trials have used intravascular ultrasound (IVUS). Optical coherence ...